![]()
|
Report Date : |
04.06.2008 |
IDENTIFICATION
DETAILS
|
Name : |
QUALICARE PHARMACEUTICALS PRIVATE LIMITED |
|
|
|
|
Registered Office : |
G-8, Emerald Amrutha Hills, Panjagutta, Hyderabad – 500 082, Andhra
Pradesh |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2006 |
|
|
|
|
Date of Incorporation : |
18.11.1985 |
|
|
|
|
Com. Reg. No.: |
01-5955 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24239AP1985PTC005955 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
HYDQ00010D |
|
|
|
|
Legal Form : |
Private Limited Liability Company
|
|
|
|
|
Line of Business : |
Manufacturer of Pharmaceuticals Formulations |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 70000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well – established and reputed company meeting its normal timeously. Trade relations are fair.
Business is active. The company can be considered good for normal business dealings. |
INFORMATION PARTED
BY
|
Name : |
Mr. Shivrama Krishna |
|
Designation : |
Purchase Manager |
|
Date : |
04.06.2008 |
LOCATIONS
|
Registered Office : |
G-8, Emerald Amrutha Hills, Panjagutta, Hyderabad – 500 082, Andhra
Pradesh, India |
|
Tel. No.: |
91-40-66666306 |
|
Mobile No.: |
91-9391330665 |
|
E-Mail : |
|
|
Area: |
1000 Sq.fts |
|
Location: |
Rented |
|
|
|
|
Factory : |
Plot 103/C, Sri Vanketeshwara, Co-op Industrial Estate, Bollaram – 502
325, Medak District, Andhra Pradesh, India |
|
Tel No.: |
91-40-65884028 |
|
|
|
|
Branch: |
Dehradun -
248001, Uttar Pradesh, India |
DIRECTORS
|
Name : |
Mr. K S N Murthy |
|
Designation : |
Director |
|
Address: |
2-2-1137/8/1/A, New Nallakunta, Hyderabad – 500 082, Andhra Pradesh,
India |
|
Date of Birth/Age : |
50 years |
|
Qualification : |
B. Com |
|
Date of
Appointment : |
18.11.1985 |
|
|
|
|
Name : |
Mr. C H Sumana |
|
Designation : |
Director |
|
|
D /O, C H Nageswara Rao, 211, emerald House, Punjagutta , Hyderabad –
500 082, Andhra Pradesh, India |
|
Date of Birth/Age : |
25 years |
|
Qualification : |
BE. MS |
|
|
|
|
Name : |
Mr. C H Vasanta |
|
Designation : |
Director |
|
Date of Birth/Age : |
50 years |
|
Qualification : |
B.Sc |
SHAREHOLDING
PATTERN
Equity Shares Breakup (Percentage of Total Equity): as on 31.03.2007:-
|
Sr No. |
Category |
Percentage |
|
1 |
Directors or relative of directors |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Pharmaceuticals Formulations |
|
|
|
|
Exports : |
|
|
Countries : |
UK, Asian Countries |
|
|
|
|
Imports : |
|
|
Countries : |
USA, China |
|
|
|
|
Terms : |
|
|
Selling : |
Credit |
|
|
|
|
Purchasing : |
Cash, Credit (30 Days) |
GENERAL
INFORMATION
|
No. of Employees : |
125 (5 in Office and 120 in Factory) |
|
|
|
|
Bankers : |
· Manasa Co-operative Urban Bank Limited M G Road,
Secunderabad – 500 003 · Cosmos Bank (Facilities: C/C
- Rs. 3.000 millions ) |
|
|
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
Auditors : |
|
|
Name : |
P Murali Mohana Rao Chartered Accountants |
|
Address : |
6-3-655/2/3, Somaji Guda, Andhra Pradesh, India |
|
|
|
|
Associates/Subsidiaries : |
Nil |
CAPITAL STRUCTURE
As on 31.03.2007:-
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
500000 |
Equity Shares |
Rs. 10/- each |
Rs. 5.000 millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
500000 |
Equity Shares |
Rs. 10/-
each |
Rs. 5.000
millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
|
31.03.2006 |
31.03.2005 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
|
5.000 |
2.500 |
|
|
2] Share Application Money |
|
0.000 |
2.500 |
|
|
3] Reserves & Surplus |
|
7.985 |
7.039 |
|
|
4] (Accumulated Losses) |
|
0.000 |
0.000 |
|
|
NETWORTH |
|
12.985 |
12.039 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
3.740 |
4.488 |
|
|
2] Unsecured Loans |
|
0.000 |
0.000 |
|
|
TOTAL BORROWING |
|
3.740 |
4.488 |
|
|
DEFERRED TAX LIABILITIES |
|
2.970 |
3.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
19.695 |
19.527 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
15.024 |
15.796 |
|
|
Capital work-in-progress |
|
0.360 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
0.864 |
0.599 |
|
|
Sundry Debtors |
|
13.528 |
18.332 |
|
|
Cash & Bank Balances |
|
0.104 |
0.080 |
|
|
Other Current Assets |
|
0.000 |
0.000 |
|
|
Loans & Advances |
|
3.070 |
1.150 |
|
Total
Current Assets |
|
17.566 |
20.161 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
|
13.255 |
16.430 |
|
|
Provisions |
|
0.000 |
0.000 |
|
Total
Current Liabilities |
|
13.255 |
16.430 |
|
|
Net Current Assets |
|
4.311 |
3.731 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
19.695 |
19.527 |
|
KEY RATIOS
|
PARTICULARS |
|
|
31.03.2006 |
31.03.2005 |
|
Debt Equity Ratio (Total Liability/Networth) |
|
|
1.31 |
1.74 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
|
1.33 |
1.23 |
LOCAL AGENCY
FURTHER INFORMATION
FORM 8:-
|
Name of the
company |
QUALICARE PHARMACEUTICALS LIMITED |
|
Presented By |
Mr. Vasantha ,
Director |
|
1) Date and description
of instrument creating the change |
Agreement for
hypothecation of goods and book debts to secure cash credit facility, dated
01.11.2004 |
|
2) Amount secured
by the charge/amount owing on the securities of charge |
Rs. 3.000
millions |
|
3) Short
particular of the property charged. If the property acquired is subject to
charge, date of the acquired of the property should be given |
Hypothecation of
stocks of chemicals, raw materials, stocks in process, packing materials and
finished goods. |
|
4) Gist of the
terms and conditions and extent and operation of the charge. |
Rate of Interest
@ 15% . Repayable on demand. |
|
5) Name and
Address and description of the person entitled to the charge. |
Manasa Co-operative Urban Bank Limited M G Road, Secunderabad – 500 003 |
|
6) Date and brief description of instrument
modifying the charge |
NA |
|
7) Particulars of
modifications specifying the terms and conditions or the extent of operations
of the charge in which modification is made and the details of the
modification. |
NA |
TRADE REFERENCES:
(Customers)
· FDC Limited
· Merisant India Limited
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market survey
revealed that the amount of compensation sought by the subject is fair and
reasonable and comparable to compensation paid to others for similar services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.42.53 |
|
UK Pound |
1 |
Rs.83.44 |
|
Euro |
1 |
Rs.66.18 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
4 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
--- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|